Adelaide Advertiser 26/05/2009 Stock Watch 'BNO' The company's anti-anxiety drug BNC210 will proceed to human clinical trials after approval from the Therapeutic Goods Administration.
BNO Price at posting:
24.4¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.